Targeting miRNA in brain tumors.

靶向脑肿瘤中的 miRNA。

基本信息

  • 批准号:
    7140159
  • 负责人:
  • 金额:
    $ 14.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-29 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): MicroRNAs (miRNAs) are a recently discovered class of small 20-22 nucleotide non-coding RNA molecules that have been shown to regulate target gene expression in various organisms. By targeting the mRNA of protein-coding genes for either cleavage or repression of translation, miRNAs are thought to play critical roles in development, control of growth, proliferation, and cell lineage determination. However, the ability of this new class of regulatory RNAs to influence the processes of proliferation and differentiation in malignancy remains to be uncovered. Using an oligonucleotide array designed to detect the majority of mammalian miRNAs identifies thus far, we measured the expression levels of miRNAs in glioblastomas. This preliminary study identified a cluster of miRNAs that is up-regulated in glioblastomas. Among this cluster one miRNA is markedly elevated. Sequence-specific inhibition of this miRNA with modified antisense oligonucleotides induces apoptosis of glioblastoma cells in culture, suggesting a role for this miRNA in gliomagenesis. Similar regulatory miRNA molecules unique to tumor cells may exist and can serve as prognostic markers and, probably, excellent therapeutic targets for the treatment of high-grade brain tumors. The long-term goal of this proposal is to treat glioblastomas by targeting miRNAs. The immediate goal over the next two years is the development of technologies required for identification and validation of miRNA targets. We will create an oligonucleotide array for the complete profiling of miRNA expression in glioblastomas and characterize molecules expressed exclusively in these tumors. We will then develop ways to suppress these miRNAs in glioblastoma cell cultures and assess the effects on the migratory, apoptotic, and proliferative capacity of the tumor cells. Furthermore, we will test the potential of the miRNA inhibitors in animal models in vivo. Although beyond the scope of this proposal, in the ensuing years we will study downstream mRNA and protein targets that mediate miRNA functions. The results of the experiments proposed here will improve our understanding of biology of brain rumors. Moreover, miRNA targeting technology developed in this research could open the door to novel treatments of glioblastoma.
描述(由申请人提供):MicroRNAs (miRNAs)是最近发现的一类小的20-22个核苷酸的非编码RNA分子,已被证明在各种生物体中调节靶基因的表达。通过靶向蛋白质编码基因的mRNA进行切割或抑制翻译,mirna被认为在发育、生长、增殖控制和细胞谱系确定中起着关键作用。然而,这类新的调控rna影响恶性肿瘤增殖和分化过程的能力仍有待发现。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MicroRNA profiling: from dark matter to white matter, or identifying new players in neurobiology.
  • DOI:
    10.1100/tsw.2007.201
  • 发表时间:
    2007-11-02
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Krichevsky AM
  • 通讯作者:
    Krichevsky AM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna M. Krichevsky其他文献

HOXDeRNA activates a cancerous transcription program and super enhancers via genome-wide binding
  • DOI:
    10.1016/j.molcel.2024.09.018
  • 发表时间:
    2024-10-17
  • 期刊:
  • 影响因子:
  • 作者:
    Evgeny Deforzh;Prakash Kharel;Yanhong Zhang;Anton Karelin;Abdellatif El Khayari;Pavel Ivanov;Anna M. Krichevsky
  • 通讯作者:
    Anna M. Krichevsky
Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism
胶质母细胞瘤衍生的细胞外囊泡通过重编程致癌代谢促进星形胶质细胞的转化
  • DOI:
    10.1016/j.isci.2020.101420
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Ailiang Zeng;Zhiyun Wei;Rosalia Rabinovsky;Hyun Jung Jun;Rachid El Fatimy;Evgeny Deforzh;Ramil Arora;Yizheng Yao;Shun Yao;Wei Yan;Erik J. Uhlmann;Alain Charest;Yongping You;Anna M. Krichevsky
  • 通讯作者:
    Anna M. Krichevsky
Noncoding RNAs in the Brain
大脑中的非编码 RNA
  • DOI:
    10.1523/jneurosci.3624-07.2007
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. Satterlee;S. Barbee;P. Jin;Anna M. Krichevsky;S. Salama;G. Schratt;Da
  • 通讯作者:
    Da
A Model for Local Regulation of Translation Near Active Synapses
活动突触附近翻译的局部调节模型
  • DOI:
    10.1126/stke.3002005tr25
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K. Kosik;Anna M. Krichevsky
  • 通讯作者:
    Anna M. Krichevsky
The Enkephalinergic Osteoblast
脑啡肽能成骨细胞

Anna M. Krichevsky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anna M. Krichevsky', 18)}}的其他基金

Epigenetics and 3D structure of miR-10b/HoxD locus in the brain and malignant glioma.
大脑和恶性胶质瘤中 miR-10b/HoxD 位点的表观遗传学和 3D 结构。
  • 批准号:
    10452679
  • 财政年份:
    2020
  • 资助金额:
    $ 14.7万
  • 项目类别:
Epigenetics and 3D structure of miR-10b/HoxD locus in the brain and malignant glioma.
大脑和恶性胶质瘤中 miR-10b/HoxD 位点的表观遗传学和 3D 结构。
  • 批准号:
    10255993
  • 财政年份:
    2020
  • 资助金额:
    $ 14.7万
  • 项目类别:
Testing miR-132 signaling and replacement as a common strategy for AD, FTD, and related pathologies
测试 miR-132 信号传导和替代作为 AD、FTD 和相关病理的常见策略
  • 批准号:
    10228414
  • 财政年份:
    2020
  • 资助金额:
    $ 14.7万
  • 项目类别:
Developing miR-10b targeting for glioblastoma
开发针对胶质母细胞瘤的 miR-10b 靶向药物
  • 批准号:
    10353413
  • 财政年份:
    2018
  • 资助金额:
    $ 14.7万
  • 项目类别:
Validation of microRNA Targets in Glioma
胶质瘤中 microRNA 靶标的验证
  • 批准号:
    8010662
  • 财政年份:
    2010
  • 资助金额:
    $ 14.7万
  • 项目类别:
Validation of microRNA Targets in Glioma
胶质瘤中 microRNA 靶点的验证
  • 批准号:
    8391230
  • 财政年份:
    2010
  • 资助金额:
    $ 14.7万
  • 项目类别:
Validation of microRNA Targets in Glioma
胶质瘤中 microRNA 靶标的验证
  • 批准号:
    8586305
  • 财政年份:
    2010
  • 资助金额:
    $ 14.7万
  • 项目类别:
Validation of microRNA Targets in Glioma
胶质瘤中 microRNA 靶点的验证
  • 批准号:
    8197277
  • 财政年份:
    2010
  • 资助金额:
    $ 14.7万
  • 项目类别:
Validation of microRNA Targets in Glioma
胶质瘤中 microRNA 靶标的验证
  • 批准号:
    7784108
  • 财政年份:
    2010
  • 资助金额:
    $ 14.7万
  • 项目类别:
Targeting miRNA in brain tumors.
靶向脑肿瘤中的 miRNA。
  • 批准号:
    6962131
  • 财政年份:
    2005
  • 资助金额:
    $ 14.7万
  • 项目类别:

相似海外基金

A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
  • 批准号:
    10597799
  • 财政年份:
    2023
  • 资助金额:
    $ 14.7万
  • 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
  • 批准号:
    10385037
  • 财政年份:
    2022
  • 资助金额:
    $ 14.7万
  • 项目类别:
Model-driven Media Optimization in Hybridoma Cell Line
杂交瘤细胞系中模型驱动的培养基优化
  • 批准号:
    7154904
  • 财政年份:
    2006
  • 资助金额:
    $ 14.7万
  • 项目类别:
A basic study on the development of bioartificial pancreas using a highly differentiated human pancreatic beta cell line.
使用高度分化的人胰腺β细胞系开发生物人工胰腺的基础研究。
  • 批准号:
    18390347
  • 财政年份:
    2006
  • 资助金额:
    $ 14.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A CELL LINE FOR ANTIASTHMA DRUG DISCOVERY
用于发现抗哮喘药物的细胞系
  • 批准号:
    6742891
  • 财政年份:
    2004
  • 资助金额:
    $ 14.7万
  • 项目类别:
Homologous Recombination in a Secretory Mouse Cell Line
分泌型小鼠细胞系中的同源重组
  • 批准号:
    6683289
  • 财政年份:
    2001
  • 资助金额:
    $ 14.7万
  • 项目类别:
Homologous Recombination in a Secretory Mouse Cell Line
分泌型小鼠细胞系中的同源重组
  • 批准号:
    6572294
  • 财政年份:
    2001
  • 资助金额:
    $ 14.7万
  • 项目类别:
NOVEL E1 CELL LINE FOR RCA-FREE ADENOVIRAL GENE THERAPY
用于无 RCA 腺病毒基因治疗的新型 E1 细胞系
  • 批准号:
    6211901
  • 财政年份:
    2001
  • 资助金额:
    $ 14.7万
  • 项目类别:
MOLECULAR CLONING OF A T(15;19) IN LUNG CANCER CELL LINE
肺癌细胞系中 T(15;19) 的分子克隆
  • 批准号:
    6845072
  • 财政年份:
    2000
  • 资助金额:
    $ 14.7万
  • 项目类别:
MOLECULAR CLONING OF A T(15;19) IN LUNG CANCER CELL LINE
肺癌细胞系中 T(15;19) 的分子克隆
  • 批准号:
    6619443
  • 财政年份:
    2000
  • 资助金额:
    $ 14.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了